We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Two New Nationwide Surveys, Conducted by Amplifon Hearing Health Care, Show the Importance of Provider Recommendations and Access to Options on Consumer Experience Hearing benefits that include...
Amplifon confirms its focus on the importance of safe listening as WHO highlights the increase of young adults living with and at risk of developing hearing loss In America, 45 million people...
Innovative virtual solution designed to increase access to care, hearing aid use, patient convenience and health plan savings Amplifon Hearing Health Care, the leading independent provider of...
Hearing Loss May Lead to an Increased Feeling of Isolation in Seniors Currently in Quarantine An estimated 1 out of every 3 individuals over the age of 65 has some degree of hearing loss...
Untreated Hearing Loss Has Been Linked to Serious Health Conditions Such as Depression, Dementia, Alzheimer’s and Diabetes. October is National Depression Education and Awareness Month: a topic...
The Required Use of Face Masks Tied to the Ongoing COVID-19 Pandemic Have Provided Challenges for Those With Hearing Loss. Learn Easy Ways You Can Help. The COVID-19 pandemic continues to change...
Achievement Demonstrates a Strong Commitment to the Highest Standards in Hearing Health Care Amplifon Hearing Health Care, a leading player in hearing benefit solutions, has earned...
Elite Hearing Network, a subsidiary of Amplifon S.p.A. (“Amplifon” or the “Company”; MTA; Bloomberg ticker: AMP:IM) global leader in hearing healthcare solutions and services, has named...
#HearWellStayVital Campaign Embraced by Newly Appointed Hearing Industries Association Board Member, Marc C. Lundeberg, Amplifon Americas Executive Vice President Amplifon S.p.A...
In Europe today, markets have gotten off to a healthy second-quarter start following a rebound in Chinese manufacturing activity, while new data shows Eurozone inflation remains below the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.81 | -3.38487254492 | 23.93 | 24.13 | 23.11 | 633192 | 23.68506211 | DE |
4 | -4.25 | -15.5279503106 | 27.37 | 27.8 | 23.11 | 725081 | 25.10643188 | DE |
12 | -6.03 | -20.6861063465 | 29.15 | 29.67 | 23.11 | 721410 | 26.47489508 | DE |
26 | -11.28 | -32.7906976744 | 34.4 | 35.14 | 23.11 | 648532 | 28.79098967 | DE |
52 | -5.07 | -17.9851010997 | 28.19 | 35.14 | 23.11 | 602544 | 29.96343977 | DE |
156 | -21.67 | -48.3813351194 | 44.79 | 47.59 | 23.11 | 603553 | 30.87543693 | DE |
260 | -1.98 | -7.88844621514 | 25.1 | 47.59 | 14.83 | 644997 | 30.67820443 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions